Hybrid View
-
11-17-2014, 04:03 AM #1
Lemtrada (alemtuzumab) approved by FDA for U.S.
It was announced November 14th 2014 that the U.S. FDA approved the use of Lemtrada (alemtuzumab) for relapsing-remitting Multiple Sclerosis. To read more information, click here.
Ashley Ringstaff
Ringer1319/RingpOP
MSWorld Volunteer
Living with MS since 8/30/10